List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 262 studies with search of: "Aldesleukin"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Aldesleukin in Patients With Metastatic Renal Cell Carcinoma and Metastatic Melanoma
Conditions: Metastatic Renal Cell Carcinoma;   Metastatic Melanoma
Intervention: Drug: Aldesleukin
2 Active, not recruiting Effect of Intermittent Aldesleukin Treatment With or Without Anti-HIV Drugs in HIV Infected People
Condition: HIV Infections
Intervention: Drug: Aldesleukin
3 Recruiting The High-Dose Aldesleukin (IL-2) "Select" Trial for Patients With Metastatic Renal Cell Carcinoma
Condition: Metastatic Renal Cell Carcinoma
Intervention: Drug: aldesleukin (Proleukin)
4 Completed A Phase I Study of Subcutaneously Administered Proleukin (Aldesleukin) in HIV-Infected Patients
Condition: HIV Infections
Intervention: Drug: Aldesleukin
5 Recruiting Adjuvant, Combined Interleukin 2 (Proleukin) and DTIC (Dacarbazine) in High-Risk Melanoma Patients
Condition: Metastatic Melanoma
Intervention: Drug: Proleukin and Dacarbazine
6 Completed A Phase I Study of the Safety of Proleukin (Aldesleukin) in Combination With Ganciclovir and Antiretroviral Therapy in HIV Seropositive Patients With Cytomegalovirus (CMV) Retinitis
Conditions: Cytomegalovirus Retinitis;   HIV Infections
Intervention: Drug: Aldesleukin
7 Active, not recruiting An International Study to Evaluate Anti-HIV Therapy Plus Interleukin-2 (rIL-2) in HIV Positive Patients
Condition: HIV Infections
Intervention: Drug: Aldesleukin
8 Recruiting Laboratory-Treated Autologous Peripheral Blood Lymphocytes, Aldesleukin, Cyclophosphamide, and Fludarabine in Treating Patients With Metastatic Melanoma
Condition: Melanoma (Skin)
Intervention: Biological: aldesleukin
9 Active, not recruiting Subcutaneously Administered Aldesleukin ( Interleukin-2; IL-2 ) Therapy in HIV-Infected Patients
Condition: HIV Infections
Intervention: Drug: Aldesleukin
10 Completed Chemotherapy Followed By Autologous Natural Killer Cells and Aldesleukin in Treating Patients With Metastatic Melanoma or Kidney Cancer
Conditions: Kidney Cancer;   Melanoma (Skin)
Interventions: Biological: aldesleukin;   Biological: therapeutic autologous lymphocytes;   Drug: cyclophosphamide;   Drug: fludarabine phosphate
11 Terminated Trial of Outpatient Immunotherapy With Rituximab and Aldesleukin (IL-2) vs. Rituximab Alone for Non-Hodgkin's Lymphoma
Condition: Non-Hodgkin's Lymphoma
Interventions: Drug: Rituximab;   Drug: Aldesleukin
12 Recruiting Interleukin-2 With Sorafenib (BAY 43-9006) for Unresectable or Metastatic Clear Cell Renal Carcinoma (RCC) and Metastatic Melanoma
Conditions: Renal Cancer;   Melanoma
Interventions: Drug: Aldesleukin;   Drug: Sorafenib
13 Recruiting Intralesional Treatment With Interleukin-2 (Proleukin) in Soft Tissue Melanoma Metastases
Condition: Melanoma
Intervention: Drug: Interleukin-2 (Proleukin)
14 Completed A Phase II Study of Intermittent Recombinant Human Interleukin-2 (rhIL-2) by Intravenous or Subcutaneous Administration in Subjects With HIV Infection on Highly Active Antiretroviral Therapy (HAART) Compared to HAART Alone
Condition: HIV Infections
Interventions: Drug: Indinavir sulfate;   Drug: Lamivudine;   Drug: Stavudine;   Drug: Zidovudine;   Drug: Didanosine;   Drug: Aldesleukin
15 Completed A Study to Evaluate the Effects of Giving Proleukin (rIL-2) to HIV-Positive Patients With CD4 Counts Greater Than 300 Cells/mm3
Condition: HIV Infections
Intervention: Drug: Aldesleukin
16 Recruiting Aldesleukin in Treating Patients With Metastatic Melanoma or Metastatic Kidney Cancer
Conditions: Kidney Cancer;   Melanoma (Skin)
Intervention: Biological: aldesleukin
17 Recruiting Aldesleukin With or Without Vaccine Therapy in Treating Patients With Stage IV Melanoma
Condition: Melanoma (Skin)
Interventions: Biological: aldesleukin;   Biological: allogeneic large multivalent immunogen melanoma vaccine LP2307
18 Recruiting Vaccine Therapy and Aldesleukin in Treating Women With Metastatic Breast Cancer
Condition: Breast Cancer
Interventions: Biological: aldesleukin;   Biological: allogeneic large multivalent immunogen breast cancer vaccine;   Other: flow cytometry;   Other: immunoenzyme technique;   Other: laboratory biomarker analysis
19 Not yet recruiting A Study to Evaluate the Use of a Protease Inhibitor and of Interleukin-2 (IL-2) in the Treatment of Early HIV Infection
Condition: HIV Infections
Interventions: Drug: Indinavir sulfate;   Drug: Ritonavir;   Drug: Abacavir sulfate;   Drug: Efavirenz;   Drug: Stavudine;   Drug: Didanosine;   Drug: Aldesleukin
20 Active, not recruiting Interferon-Gamma or Aldesleukin and Vaccine Therapy in Treating Patients With Multiple Myeloma
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Interventions: Biological: aldesleukin;   Biological: idiotype-pulsed autologous dendritic cell vaccine APC8020;   Biological: recombinant interferon gamma;   Genetic: polymerase chain reaction;   Genetic: reverse transcriptase-polymerase chain reaction;   Other: flow cytometry;   Other: laboratory biomarker analysis

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services